UCSF's Nicole Paulk discusses AAV as a gene therapy vector
How CAR-T and gene therapies are shipped
The latest on immunotherapy with John Connolly.
Talking BCMA CAR-T at #JPM23
Antibody-drug conjugates with David Epstein
AI in biotech with Generate Biomedicines’ Mike Nally
Justin Zelin's take on #JPM23 news.
Stéphane Bancel discusses Moderna's personalized cancer vaccine at #JPM23
Rachel Haurwitz on allo CAR-T at #JPM23
Kite Pharma's Kristi Shaw talks cell therapy at #JPM23
A top biotech dealmaker on the M&A outlook for 2023
BeiGene on BTK Inhibitors and the Inflation Reduction Act.
A biotech veteran gives his take on volatile times and allo CAR-T.
TCR therapies as a new modality in cancer treatment
Luke Timmerman at #JPM23
Beam's Therapeutics' John Evans talks base editing at #JPM23
How a16z invests in healthcare
Noubar Afeyan discusses the year ahead
Kicking off #JPM23 with Brian Skorney
Noubar Afeyan on Moderna and Biotech Innovation
.png){kind=logo}
